You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Johnson and Johnson
Colorcon
Harvard Business School
Merck

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

Patent: 10,406,213

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,406,213
Title:Injection paradigm for administration of botulinum toxins
Abstract: Methods for treating a patient suffering from a medication overuse headache disorder are provided. The methods comprise administering to a patient suffering from a medication overuse disorder a Clostridial toxin. The toxin is administered to the frontalis, corrugator, procerus, occipitalis, temporalis, trapezius and cervical paraspinal muscles of the patient.
Inventor(s): Turkel; Catherine C. (Newport Coast, CA), Aurora; Sheena K. (Seattle, WA), Brin; Mitchell F. (Newport Beach, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:15/707,452
Patent Claims:see list of patent claims

Details for Patent 10,406,213

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 001 1991-12-09   Start Trial Allergan, Inc. (Irvine, CA) 2030-03-30 RX search
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 002 1991-12-09   Start Trial Allergan, Inc. (Irvine, CA) 2030-03-30 RX search
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 003 1991-12-09   Start Trial Allergan, Inc. (Irvine, CA) 2030-03-30 RX search
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 004 1991-12-09   Start Trial Allergan, Inc. (Irvine, CA) 2030-03-30 RX search
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 005 1991-12-09   Start Trial Allergan, Inc. (Irvine, CA) 2030-03-30 RX search
Ipsen Biopharm Ltd DYSPORT abobotulinumtoxina INJECTABLE; INJECTION 125274 001 2009-04-29   Start Trial Allergan, Inc. (Irvine, CA) 2030-03-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Boehringer Ingelheim
McKesson
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.